Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

November 11, 2022

Study Completion Date

December 7, 2022

Conditions

InfluenzaRespiratory Viral Infection

Interventions

DRUG

XC8

A single dose of R or T drug in each of 2 periods of the study in fasted conditions

Trial Locations (1)

I.M. Sechenov First Moscow State Medical University, Moscow

All Listed Sponsors

lead

Valenta Pharm JSC

INDUSTRY